Protection from obesity-induced insulin resistance in mice lacking TNF-α function
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitus. The molecular basis of this common syndrome, however, is poorly understood. It has been suggested that tumour necrosis factor (TNF)-alpha is a candidate mediator of insulin resistance in obesity, as it is overexpressed in the adipose tissues of rodents and humans and it blocks the action of insulin in cultured cells and whole animals. To investigate the role of TNF-alpha in obesity and insulin resistance, we have generated obese mice with a targeted null mutation in the gene encoding TNF-alpha and those encoding the two receptors for TNF-alpha. The absence of TNF-alpha resulted in significantly improved insulin sensitivity in both diet-induced obesity and that resulting for the ob/ob model of obesity. The TNFalpha-deficient obese mice had lower levels of circulating free fatty acids, and were protected from the obesity-related reduction in the insulin receptor signalling in muscle and fat tissues. These results indicate that TNF-alpha is an important mediator of insulin resistance in obesity through its effects on several important sites of insulin action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a number of animal studies where inflammatory pathways are genetically down regulated demonstrate that preventing obesity induced inflammation can prevent the development of insulin resistance [159,160].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [159]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“gif" NDATA ITEM> ]> Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitu”
BackgroundWhite, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
The Mouse in Biomedical Research
(1983) · Elsevier eBooks · doi:10.1016/c2013-0-10677-0 · Cited by 1,012
Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 932 · cited 1×
“To test the importance of the TNFα-activated pathway of insulin resistance in the most severe, genetic model of obesity, we generated genetically obese ( ob/ob ) mice with targeted mutations in both p55 and p75 TNF receptors, effectively abolishing the signalling and function of TNF-α in these animal”
BackgroundHotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Research works printed but not linked: 1
- Olefsky, J. M. & Molina, J. M. in Diabetes Mellitus (eds Rifkin, H. & Porte, D. J.) 121–153 (Elsevier, New York, (1990)).
Cited by
Items 501–600 of 1,010
Inactivation of TNF-α ameliorates diabetic neuropathy in mice
Yamakawa, I., Kojima, H., Terashima, T., Katagi, M., Oi, J., Urabe, H., Sanada, M., Kawai, H., Chan, L., Yasuda, H., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00029.2011 · Cited by 146
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy
Oike, Y., Akao, M., Kubota, Y., & Suda, T. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.08.002 · Cited by 155
van der Voort, E. A. M., Koehler, E. M., Dowlatshahi, E. A., Hofman, A., Stricker, B. H., Janssen, H. L. A., Schouten, J. N. L., & Nijsten, T. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.044 · Cited by 145
Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome
Cooke, A. A., Connaughton, R. M., Lyons, C. L., McMorrow, A. M., & Roche, H. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.021 · Cited by 152
Papaetis, G. S., Papakyriakou, P., & Panagiotou, T. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.52350 · Cited by 130
“Hence, results from these studies must be interpreted with caution [34, 35, 39, 40–43, 54, 67, 75, 76, 83–85, 88, 89, 95–98, 172–174, 178–180, 183–185, 198].”
BackgroundDuncan, B. B., Schmidt, M. I., Chambless, L. E., Folsom, A. R., Carpenter, M., Heiss, G., & for the ARIC Investigators (2000) · Obesity Research · doi:10.1038/oby.2000.33 · Cited by 146
Adipocyte, Adipose Tissue, and Infectious Disease
Desruisseaux, M. S., Nagajyothi, Trujillo, M. E., Tanowitz, H. B., & Scherer, P. E. (2007) · Infection and Immunity · doi:10.1128/iai.01455-06 · Cited by 142
“Some adipose tissue-derived inflammatory cytokines such as TNFare not secreted into the circulation to any significant extent and are only elevated locally; however, increases in adipose tissue expression of TNF- contribute to changes in wholebody metabolism and the in vivo hormonal milieu (127).”
BackgroundInnate Immune Cells in the Adipose Tissue in Health and Metabolic Disease
Michailidou, Z., Gomez-Salazar, M. A., & Alexaki, V. I. (2021) · Journal of Innate Immunity · doi:10.1159/000515117 · Cited by 159
The Interplay between Obesity and Inflammation
Săvulescu-Fiedler, I., Mihalcea, R., Dragosloveanu, Ş., Scheau, C., Baz, R. O., Căruntu, A., Scheau, A.-E., Căruntu, C., & Benea, S. N. (2024) · Life · doi:10.3390/life14070856 · Cited by 161
“The WAT releases a large number of adipokines that either show anti-inflammatory effects or promote inflammation, and releases insulin resistance-inducing CKs [218,219] (Figure 3).”
BackgroundNawrocki, A., & Scherer, P. E. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.003 · Cited by 169
Nagy, L. E. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132258 · Cited by 145
Plasminogen activator inhibitor-1 modulates adipocyte differentiation
Liang, X., Kanjanabuch, T., Mao, S.-L., Hao, C.-M., Tang, Y.-W., Declerck, P. J., Hasty, A. H., Wasserman, D. H., Fogo, A. B., & Ma, L.-J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00605.2004 · Cited by 136
Daulatzai, M. A. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1266-6 · Cited by 155
“Conversely, TNF-α null mice showed improved metabolic homeostasis [106].”
BackgroundKeynote review: The adipocyte as a drug discovery target
Nawrocki, A. R., & Scherer, P. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03569-5 · Cited by 155
Engelman, J. A., Berg, A. H., Lewis, R. Y., Lisanti, M. P., & Scherer, P. E. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.10.0542 · Cited by 138
Seo, J. B., Moon, H. M., Noh, M. J., Lee, Y. S., Jeong, H. W., Yoo, E. J., Kim, W. S., Park, J., Youn, B.-S., Kim, J. W., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400238200 · Cited by 139
The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis
Liang, C.-P., Han, S., Senokuchi, T., & Tall, A. R. (2007) · Circulation Research · doi:10.1161/circresaha.107.152165 · Cited by 143
Oliver, E., McGillicuddy, F., Phillips, C., Toomey, S., & Roche, H. M. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110000042 · Cited by 136
The Role of Chronic Inflammation in Obesity-Associated Cancers
Ramos-Nino, M. E. (2013) · ISRN Oncology · doi:10.1155/2013/697521 · Cited by 127
Increased pulmonary responses to acute ozone exposure in obese db/db mice
Lu, F. L., Johnston, R. A., Flynt, L., Theman, T. A., Terry, R. D., Schwartzman, I. N., Lee, A., & Shore, S. A. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00386.2005 · Cited by 151
“In humans, obesity-related systemic inflammation is likely functionally important, as it correlates with diseases of the metabolic syndrome including Type 2 diabetes and atherosclerosis (5, 58).”
BackgroundObesity-mediated inflammation may damage the brain circuit that regulates food intake
Cazettes, F., Cohen, J. I., Yau, P. L., Talbot, H., & Convit, A. (2011) · Brain Research · doi:10.1016/j.brainres.2010.12.008 · Cited by 129
“…proves that fat-rich diet induces an inflammatory status in the hypothalamus and triggers the resistance to anorexigenic signals (De Souza et al., 2005; Milanski et al., 2009) and inflammation, in combination with obesity, may result in the dysregulation of insulin signaling (Uysal et al., 1997).”
BackgroundCranmer, M. (2000) · Toxicological Sciences · doi:10.1093/toxsci/56.2.431 · Cited by 143
for the CIRCS Investigators, Muraki, I., Tanigawa, T., Yamagishi, K., Sakurai, S., Ohira, T., Imano, H., Kitamura, A., Kiyama, M., Sato, S., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1616-0 · Cited by 148
“TNF-α) [19], leading to increased insulin resistance [20].”
BackgroundChrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ
Feng, X., Qin, H., Shi, Q., Zhang, Y., Zhou, F., Wu, H., Ding, S., Niu, Z., Lü, Y., & Shen, P. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.03.016 · Cited by 147
Poulsen, M. M., Fjeldborg, K., Ørnstrup, M. J., Kjær, T. N., Nøhr, M. K., & Pedersen, S. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.024 · Cited by 145
Johnston, R. A., Theman, T. A., Lu, F. L., Terry, R. D., Williams, E. S., & Shore, S. A. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00075.2008 · Cited by 144
Chronic Hepatitis C Is Associated With Peripheral Rather Than Hepatic Insulin Resistance
Milner, K., van der Poorten, D., Trenell, M. I., Jenkins, A. B., Xu, A., Smythe, G. A., Dore, G. J., Zekry, A., Weltman, M., Fragomeli, V., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.11.050 · Cited by 151
Interleukin-1ß induces the novel adipokine chemerin in adipocytes in vitro
Kralisch, S., Weise, S., Sommer, G., Lipfert, J., Lössner, U., Blüher, M., Stümvoll, M., & Faßhauer, M. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.02.010 · Cited by 152
Fischer-Posovszky, P., Wang, Q. A., Asterholm, I. W., Rutkowski, J. M., & Scherer, P. E. (2011) · Endocrinology · doi:10.1210/en.2011-1031 · Cited by 134
Modulation of Chronic Inflammation by Quercetin: The Beneficial Effects on Obesity
Sato, S., & Mukai, Y. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s228361 · Cited by 143
Muniyappa, R., Chen, H., Montagnani, M., Sherman, A., & Quon, M. J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00247.2020 · Cited by 320
Adipose tissue as an endocrine organ: impact on insulin resistance.
Im, J., Pijl, H., & Ae, M. (2003) · PubMed · Cited by 158
Rull, A., Camps, J., Alonso‐Villaverde, C., & Joven, J. (2010) · Mediators of Inflammation · doi:10.1155/2010/326580 · Cited by 160
Meta-analysis investigating the role of interleukin-6 mediated inflammation in type 2 diabetes
Bowker, N., Shah, R. L., Sharp, S. J., Luan, J., Stewart, I. D., Wheeler, E., Ferreira, M. A. R., Baras, A., Wareham, N. J., Langenberg, C., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103062 · Cited by 142
Vachliotis, I. D., & Pοlyzos, S. A. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00519-y · Cited by 152
Sadikot, R. T., Zeng, H., Joo, M., Everhart, M. B., Sherrill, T. P., Li, B., Cheng, D.-S., Yull, F. E., Christman, J. W., & Blackwell, T. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4923 · Cited by 136
“Marino (Sloan-Kettering Cancer Center, New York, NY), and WT (C57B/6) controls (26, 27).”
BackgroundInsulin receptor substrate proteins and diabetes
Lee, Y. H., & White, M. F. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980074 · Cited by 153
Das, U. N. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.01.002 · Cited by 156
Vascular biology of metabolic syndrome
Vykoukal, D., & Davies, M. G. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.01.003 · Cited by 127
Nisoli, E., Briscini, L., Giordano, A., Tonello, C., Wiesbrock, S. M., Uysal, K. T., Cinti, S., Carruba, M. O., & Hotamisligil, G. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8033 · Cited by 136
Self-citationTumor Necrosis Factor-α Stimulates Proliferation of Rat Ovarian Theca-Interstitial Cells1
Spaczynski, R. Z., Arici, A., & Duleba, A. J. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.4.993 · Cited by 132
Structure and physiological functions of the human peroxisome proliferator-activated receptor γ
Zieleniak, A., Wójcik, M., & Woźniak, L. A. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0037-y · Cited by 149
Role of interleukins in obesity: implications for metabolic disease
Febbraio, M. A. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.02.004 · Cited by 147
The G0/G1 switch gene 2 (G0S2): Regulating metabolism and beyond
Heckmann, B. L., Zhang, X., Xie, X., & Liu, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.09.016 · Cited by 152
Adipose Tissue Dendritic Cells Enhances Inflammation by Prompting the Generation of Th17 Cells
Chen, Y., Tian, J., Tian, X., Tang, X., Rui, K., Tong, J., Lu, L., Xu, H., & Wang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092450 · Cited by 144
Lauro, D., Kido, Y., Castle, A. L., Zarnowski, M. J., Hayashi, H., Ebina, Y., & Accili, D. (1998) · Nature Genetics · doi:10.1038/3112 · Cited by 149
Xu, L., & Ota, T. (2017) · Adipocyte · doi:10.1080/21623945.2017.1413516 · Cited by 134
Maternal cholestasis during pregnancy programs metabolic disease in offspring
Papacleovoulou, G., Abu‐Hayyeh, S., Nikolopoulou, E., Briz, Ó., Owen, B. M., Nikolova, V., Ovadia, C., Huang, X. B., Vääräsmäki, M., Baumann, M. U., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68927 · Cited by 143
Molecular pathways disrupted by gestational diabetes mellitus
Nguyen-Ngo, C., Jayabalan, N., Salomon, C., & Lappas, M. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0274 · Cited by 124
Lipophilic Micronutrients and Adipose Tissue Biology
Landrier, J., Marcotorchino, J., & Tourniaire, F. (2012) · Nutrients · doi:10.3390/nu4111622 · Cited by 154
“TNF-α was the first pro-inflammatory mediator linked to inflammation, obesity and insulin resistance [11].”
BackgroundMartín, A. S., Du, P., Dikalova, A., Lassègue, B., Aleman, M., Góngora, M. C., Brown, K., Joseph, G., Harrison, D. G., Taylor, W. R., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00943.2006 · Cited by 131
Potential Role of Tumor Necrosis Factor-α in Downregulating Sex Hormone–Binding Globulin
Simó, R., Barbosa-Desongles, A., Lecube, A., Hernandez, C., & Selva, D. M. (2012) · Diabetes · doi:10.2337/db11-0727 · Cited by 127
Age-related cerebral small vessel disease and inflammaging
Li, T., Huang, Y., Cai, W., Chen, X., Men, X., Lu, T., Wu, A., & Lu, Z. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03137-x · Cited by 124
Coughlan, M. T., Oliva, K., Georgiou, H. M., Permezel, J. M. H., & Rice, G. E. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00614.x · Cited by 128
Inflammation meets metabolic disease: Gut feeling mediated by GLP-1
Zietek, T., & Rath, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00154 · Cited by 131
Physiological, pathological and potential therapeutic roles of adipokines
Falcão‐Pires, I., Castro‐Chaves, P., Miranda‐Silva, D., Lourenço, A. P., & Leite-Moreira, A. F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.04.007 · Cited by 146
Leisegang, K., Henkel, R., & Agarwal, A. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13178 · Cited by 140
Exercise in the Metabolic Syndrome
Golbidi, S., Mesdaghinia, A., & Laher, I. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/349710 · Cited by 122
Ceramides and mitochondrial fatty acid oxidation in obesity
Fucho, R., Casals, N., Serra, D., & Herrero, L. (2016) · The FASEB Journal · doi:10.1096/fj.201601156r · Cited by 137
Hamada, D., Maynard, R., Schott, E., Drinkwater, C. J., Ketz, J. P., Kates, S. L., Jonason, J. H., Hilton, M. J., Zuscik, M. J., & Mooney, R. A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39561 · Cited by 130
“to be resistant to HF diet–induced insulin resistance and obesity (34,35), a systemic phenotype that was further confirmed herein (Figure 5).”
BackgroundRhee, Y., & Brunt, A. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-44 · Cited by 125
Inflammation at the Molecular Interface of Atherogenesis
Lamon, B. D., & Hajjar, D. P. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080442 · Cited by 144
Role of interleukin‐6 signalling in glucose and lipid metabolism
Glund, S., & Krook, A. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01779.x · Cited by 126
“Some recent studies have highlighted that one of the main functions of IL-6 is to dampen the inflammatory response, primarily by suppressing the production of tumour necrosis factor-a (TNF-a) and IL-1b (Schindler et al. 1990, Tilg et al. 1994, Xing et al. 1998, Starkie et al. 2003, Steensberg et al. 2003).”
ResultCytokines and fatty liver diseases
Niederreiter, L., & Tilg, H. (2018) · Liver Research · doi:10.1016/j.livres.2018.03.003 · Cited by 141
OHTSUKA, H., Koiwa, M., HATSUGAYA, A., Kudo, K., Hoshi, F., Itoh, N., Yokota, H., OKADA, H. M., & KAWAMURA, S. (2001) · Journal of Veterinary Medical Science · doi:10.1292/jvms.63.1021 · Cited by 128
Agudo, J., Martín, M., Roca, C., Molas, M., Bura, S. A., Zimmer, A., Bosch, F., & Maldonado, R. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1894-6 · Cited by 128
“This agrees with the enhanced insulin sensitivity that was previously reported in obese mice with reduced WAT inflammation, such as Tnf-α (also known as Tnf) [40], CCL2 or Mcp-1 [41] and osteopontin mice [42].”
BackgroundDiabetes, lipids, and adipocyte secretagogues
Faraj, M., Lu, H. L., & Cianflone, K. (2004) · Biochemistry and Cell Biology · doi:10.1139/o03-078 · Cited by 127
“Specifically in WAT, TNFα stimulates lipolysis (Kalant et al. 2003a; Sethi and Hotamisligil 1999; Uysal et al. 1997), decreases adipocyte differentiation (Torti et al.”
BackgroundInfluentialGougeon, M.-L., Pénicaud, L., Fromenty, B., Leclercq, P., Viard, J.-P., & Capeau, J. (2004) · Antiviral Therapy · doi:10.1177/135965350400900206 · Cited by 129
Oxidative Stress and Life Span Determination in the Nematode Caenorhabditis elegans
HONDA, Y., & HONDA, S. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02117.x · Cited by 123
Is interleukin-1β a culprit in macrophage-adipocyte crosstalk in obesity?
Bing, C. (2015) · Adipocyte · doi:10.4161/21623945.2014.979661 · Cited by 127
Metabolic signals and innate immune activation in obesity and exercise
Ringseis, R., Eder, K., Mooren, F. C., & Krüger, K. (2026) · PubMed · doi:10.22029/eir.2015.1696 · Cited by 123
Miyamoto, H., Moriishi, K., Moriya, K., Murata, S., Tanaka, K., Suzuki, T., Miyamura, T., Koike, K., & Matsuura, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01683-06 · Cited by 140
Auwerx, J. H. (2002) · Cited by 127
Pediatric Sleep Apnea Syndrome: An Update
Li, Z., Celestin, J., & Lockey, R. F. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.02.022 · Cited by 140
Structural development of biological response modifiers based on thalidomide
Hashimoto, Y. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00308-x · Cited by 139
Obesity-induced inflammation: connecting the periphery to the brain
Le Thuc, O., & García-Cáceres, C. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01079-8 · Cited by 125
Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis
Syn, W.-K., Choi, S. S., & Diehl, A. M. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.003 · Cited by 125
Lamia, K. A., Peroni, O. D., Kim, Y.-B., Rameh, L. E., Kahn, B. B., & Cantley, L. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.5080-5087.2004 · Cited by 120
Inflammation and Insulin Resistance
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1922 · Cited by 136
Okuno, Y., Fukuhara, A., Hashimoto, E., Kobayashi, H., Kobayashi, S., Otsuki, M., & Shimomura, I. (2018) · Diabetes · doi:10.2337/db17-1032 · Cited by 124
Kumar, K. A., Lalitha, A., Pavithra, D., Padmavathi, I. J. N., Ganeshan, M., Rao, K. R., Lagishetty, V., Balakrishna, N., Shanker, N. H., Reddy, S. U., et al. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.01.004 · Cited by 136
Increased Prevalence of the Metabolic Syndrome in Patients with Psoriatic Arthritis
Raychaudhuri, S. K., Chatterjee, S., Nguyen, C. T., Kaur, M., Jialal, I., & Raychaudhuri, S. P. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0124 · Cited by 130
Spanakis, E. K., Sidiropoulos, P. I., Papadakis, J. A., Ganotakis, E. S., Katsikas, G., Karvounaris, S. A., Bizaki, A. J., Kritikos, H. D., & Boumpas, D. T. (2006) · PubMed · Cited by 124
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 143
Akhter, N., Wilson, A., Arefanian, H., Thomas, R., Kochumon, S., Al‐Rashed, F., Abu‐Farha, M., Madhoun, A. S. A., Al‐Mulla, F., Ahmad, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015186 · Cited by 134
“…plays critical roles in various components of metabolic syndrome and substantial evidence links TNF-α with the impaired glucose tolerance and insulin resistance in individuals with obesity [10] and type 2 diabetes (T2D) [11,12], as well as in animal models of these two metabolic disorders [13].”
BackgroundHypothalamic resistin induces hepatic insulin resistance
Muse, E. D., Lam, T. K. T., Scherer, P. E., & Rossetti, L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30440 · Cited by 119
TNF-α induces mitochondrial dysfunction in 3T3-L1 adipocytes
Chen, X.-H., Zhao, Y., Xue, M., Ji, C., Gao, C., Zhu, J., Qin, D., Kou, C., Qin, X., Tong, M., et al. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.005 · Cited by 137
Luo, P., Chang, H.-H., Zhou, Y., Zhang, S., Hwang, S. H., Morisseau, C. H. P., Wang, C., Inscho, E. W., Hammock, B. D., & Wang, M.-H. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167544 · Cited by 128
“Blood glucose concentrations were determined with a glucometer at 0, 10, 30, 60, and 120 min after glucose administration (Uysal et al., 1997).”
Obesity: A neuroimmunometabolic perspective
Larabee, C. M., Neely, O. C., & Domingos, A. I. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0283-6 · Cited by 123
Elinav, E., Pappo, O., Sklair‐Levy, M., Margalit, M., Shibolet, O., Gomori, M., Alper, R., Thalenfeld, B., Engelhardt, D., Rabbani, E., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1950 · Cited by 115
“TNF receptor knockout ob/ob mice feature improved insulin sensitivity, and administration of anti-diabetic drugs Metformin and Pioglitazone, which block TNF- ̋α signalling, results in improved steatosis [45,46].”
BackgroundCTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism
Peterson, J. M., Seldin, M. M., Wei, Z., Aja, S. M., & Wong, G. W. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00102.2013 · Cited by 131
White adipose tissue and cardiovascular disease
Matsuzawa, Y. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.001 · Cited by 145
Adipocytokine Levels in Obese and Non-obese Subjects: an Observational Study
Derosa, G., Fogari, E., D’Angelo, A., Bianchi, L., Bonaventura, A., Romano, D., & Maffioli, P. (2013) · Inflammation · doi:10.1007/s10753-013-9620-4 · Cited by 133
Mast cells in human and experimental cardiometabolic diseases
Shi, G., Bot, I., & Kovanen, P. T. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.117 · Cited by 125
Li, Z., & Diehl, A. M. (2003) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200311000-00009 · Cited by 130
GENETIC MODELS OF OBESITY AND ENERGY BALANCE IN THE MOUSE
Robinson, S. W., Dinulescu, D. M., & Cone, R. D. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.687 · Cited by 132
Leptin, obesity, and liver disease
Kaplan, L. M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70272-0 · Cited by 132
An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue
Jaeschke, A., Czech, M. P., & Davis, R. J. (2004) · Genes & Development · doi:10.1101/gad.1216504 · Cited by 121
“…the adapter protein insulin receptor substrate 1 (IRS-1) on Ser 307 (Aguirre et al. 2000, 2002; Lee et al. 2003) and is strongly activated by inflammatory cytokines and free fatty acids—molecules that can contribute to the development of type 2 diabetes (Boden 1997; Uysal et al. 1997).”
BackgroundAdipose tissue as an endocrine organ
Prins, J. B. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0222 · Cited by 121
Body fat and circulating leukocytes in children
Zaldivar, F. P., McMurray, R. G., Nemet, D., Galassetti, P. R., Mills, P. J., & Cooper, D. M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803227 · Cited by 130
Metadata
- Authors
- Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S.
- Affiliations
- Harvard University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Hotamisligil, Gkhan S.
- Venue
- Nature
- Published
- 1997-10
- Volume
- 389
- Issue
- 6651
- Pages
- 610-614
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1764140709
- Cited by
- 2,234
- References
- 26
- Citations by year
- 2026: 15 · 2025: 39 · 2024: 40 · 2023: 48 · 2022: 50 · 2021: 77 · 2020: 79 · 2019: 79 · 2018: 80 · 2017: 96 · 2016: 71 · 2015: 111 · 2014: 106 · 2013: 141 · 2012: 122
- FWCI
- 33.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- TNF-α, insulin resistance, obesity, diet-induced obesity, ob/ob mice, free fatty acids, insulin receptor signaling, type 2 diabetes, adipose tissue, skeletal muscle
- MeSH terms
- Adipose Tissue, Animals, Fatty Acids, Glucose, Glucose Tolerance Test, Homeostasis, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Monosaccharide Transport Proteins, Muscle Proteins, Mutation, Obesity, Phosphorylation, Receptor, Insulin, Triglycerides, Tumor Necrosis Factor-alpha, Signal Transduction, Receptors, Tumor Necrosis Factor, Glucose Transporter Type 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.